Biotricity, Inc. (BTCY)
OTCMKTS · Delayed Price · Currency is USD
0.3000
0.00 (0.00%)
At close: Jan 2, 2026
Biotricity Market Cap
Biotricity has a market cap or net worth of $8.39 million as of January 2, 2026. Its market cap has increased by 8.06% in one year.
Market Cap
8.39M
Enterprise Value
36.69M
Revenue
15.08M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.30
Market Cap Chart
Since February 18, 2016, Biotricity's market cap has decreased from 187.13M to 8.39M, a decrease of -95.52%. That is a compound annual growth rate of -26.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 2, 2026 | 8.39M | - |
| Dec 31, 2025 | 8.39M | 17.85% |
| Dec 31, 2024 | 7.12M | -31.33% |
| Dec 29, 2023 | 10.37M | -61.10% |
| Dec 30, 2022 | 26.65M | -88.14% |
| Dec 31, 2021 | 224.72M | 464.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Feb 18, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 773.31M |
| Glass House Brands | 719.98M |
| Elite Pharmaceuticals | 537.20M |
| Northwest Biotherapeutics | 397.78M |
| Nika Pharmaceuticals | 395.17M |
| American Oncology Network | 394.40M |
| CytoDyn | 342.98M |
| Silence Therapeutics | 290.49M |